The first R&D Network in 2015 will take a closer look at antibody drug conjugates and treatment options, the use in clinical treatment and exciting new conjugated antibodies in pipeline. The registration is  now closed. Send an email to Marthe Brovold Løberg if you would like to join or have to cancel. The seminar and […]